Answers are grounded in this paper and cite their sources.
B1a B-cell subset (present as early as 4 days after birth), late-onset lymphoid cancer development, and premature death. These findings are highly similar to those observed in CLL patients and identify EBI2 as a promoter of B-cell malignancies.
No takes yet. Share an insight, caveat, or question.
Arfelt et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: